Showing 1101-1110 of 20387 results for "".
Clinical Criteria and Imaging Strategies for B7-H3–Directed ADCs in ES-SCLC
https://reachmd.com/programs/cme/clinical-criteria-and-imaging-strategies-for-b7-h3directed-adcs-in-es-sclc/39977/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.The IL-36 Connection: Immunology’s Role in GPP Pathogenesis and Therapy
https://reachmd.com/programs/cme/il-36-gpp-pathogenesis-therapy/54775/Generalized pustular psoriasis (GPP) can look familiar but missing it can have serious consequences. Uncover how IL-36 signaling and immune dysregulation shape disease presentation, progression, and treatment response. You’ll learn to distinguish GPP from other neutrophilic dermatoses using clinicalClosing the Gaps: Global Implementation of Lipid Guidelines
https://reachmd.com/programs/cme/gaps-global-implementation-lipid-guidelines/54672/A new modular CME-accredited program designed to support clinicians in translating evolving lipid guidelines into everyday practice. Delivered as a 60-minute webcast, divided into chapters for convenience, it integrates U.S. and international perspectives and focuses on equitable cardiovascular careMaking the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
https://reachmd.com/programs/cme/Making-the-Right-Moves-in-Metastatic-CSPC-Intensification-Imaging-and-Impact/56687/Experts discuss ADT intensification strategies, trial evidence, and patient selection for doublet and triplet therapy in metastatic CSPC.Treatment Intensification in HSPC: From Risk Stratification to Precision Medicine
https://reachmd.com/programs/cme/Treatment-Intensification-in-HSPC-From-Risk-Stratification-to-Precision-Medicine/56689/Explore individualized treatment intensification, molecular profiling, and adverse event management in metastatic hormone-sensitive prostate cancer.ASCVD Playbook | Closing the Gaps, One Inning at a Time
https://reachmd.com/programs/cme/ascvd-playbook-closing-the-gaps-one-inning-at-a-time/54284/Step up to the plate with evidence-based strategies to identify patients with high-risk ASCVD, optimize LDL-C, and up your game in secondary prevention.Diagnosing and Treating IBS: It Begins With One Simple Question
https://reachmd.com/programs/cme/diagnosing-and-treating-ibs-it-begins-with-one-simple-question/36607/Diagnosing and Treating IBS: It Begins With One Simple QuestionOptimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
https://reachmd.com/clinical-practice/nephrology/optimizing-igan-care-sparsentans-role-amid-the-latest-kdigo-guideline-updates/30044/Examine updated KDIGO 2025 IgAN guidelines and sparsentan’s role in managing proteinuria and slowing kidney function decline.DESTINY-Breast05: Additional Data From the Interim Analysis
https://reachmd.com/clinical-practice/oncology-hematology/destiny-breast05-additional-data-from-the-interim-analysis/49126/Check out the interim DESTINY-Breast05 analysis of T-DXd showing improved IDFS and manageable safety vs T-DM1 in high-risk HER2+ BC with residual disease.Clinical Implications of Emerging Data on B7-H3–directed ADCs in the Future of ES-SCLC
https://reachmd.com/programs/cme/clinical-implications-of-emerging-data-on-b7-h3directed-adcs-in-the-future-of-es-sclc/39979/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.